Clinical Invest Information

Pharmaceuticals
Positive Topline Results for Novartis' Leqvio® in Lowering LDL-C in Low-to-Moderate ASCVD Risk Patients Aug 28, 2024
Companies
Athira Pharma Announces Key Milestones with Upcoming Presentation of LIFT-AD Clinical Trial Results for Alzheimer's Treatment Aug 2, 2024
Healthcare
Clinical Study Validates ClarityDX Prostate's Efficacy in Predicting Prostate Cancer Risk Jun 27, 2024
Companies
argenx Unfolds its Long-term Plan 'Vision 2030' to Bring Breakthrough Science to Thousands of Patients Jun 18, 2024
Pharmaceuticals
Novartis Phase III Trial Shows Atrasentan Promising for IgA Nephropathy Treatment May 26, 2024
Companies
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma Apr 29, 2024
Companies
Athira Pharma Unveils Encouraging Clinical and Preclinical Results for Fosgonimeton at the AD/PD™ 2024 Conference Mar 9, 2024
Pharmaceuticals
SciSparc Advances Autism Spectrum Disorder Treatment with SCI-210 Clinical Trial Progression Mar 1, 2024
Finance
Projected Growth in Global Clinical Trials Outsourcing Market to Hit USD 74.38 Billion by 2031 Jan 16, 2024
Companies
MindMed's Strategic Shift in 2024: Focusing on Anxiety Treatments and Halting LSD Microdosing for ADHD Jan 11, 2024
Companies
Setback for Mirum Pharmaceuticals as Livmarli Fails in Mid-Stage Study for Biliary Atresia Dec 20, 2023
Stocks
Vigil Neuroscience (VIGL) Shares Dip Following Interim Clinical Trial Data Nov 18, 2023
Finance
Aeglea BioTherapeutics AGLE Receives Sell Rating Amid Market Dynamics Nov 13, 2023
GH Research Advances Clinical Trials for GH001 in the Fight Against Treatment-Resistant Depression Nov 9, 2023
GH Research Announces Clinical Progress and Path Forward for GH001 in the Battle Against Treatment-Resistant Depression Nov 9, 2023
GH Research Advances Clinical Development for GH001 in Treatment-Resistant Depression Nov 9, 2023